Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 7:16 PM ET


Company Overview of Biogen Hemophilia Inc.

Executive Profile

Glenn Pierce M.D., Ph.D.

Senior Vice President of Hematology, Cell and Gene Therapies, Biogen Hemophilia Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships


Dr. Glenn Pierce, Ph.D., M.D. served as senior vice president of Hematology, Cell and Gene Therapies at Biogen Idec Inc. Dr. Pierce served as Senior Vice President of Hematology, Cell and Gene Therapies of Biogen Idec Hemophilia Therapeutic Area. Dr. Pierce retired from Biogen in 2014, where he served in various roles, including as head of global medical affairs, and most recently led the Hematology, Cell and Gene Therapies division. He served as the Senior Vice President ...

Corporate Headquarters

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 781-464-3260
Fax: 866-302-9723

Board Members Memberships



Case Western Reserve University
Case Western Reserve University
Master's Degree
Washington University, St. Louis

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biogen Hemophilia Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at